286 related articles for article (PubMed ID: 37463487)
21. Comparison of renal clearance of [
Liu J; Guo X; Wen L; Wang L; Liu F; Song G; Zhu H; Zhou N; Yang Z
Eur J Nucl Med Mol Imaging; 2023 Jul; 50(9):2775-2786. PubMed ID: 37093312
[TBL] [Abstract][Full Text] [Related]
22. Preliminary evaluation of [18F]AlF-NOTA-MAL-Cys39-exendin-4 in insulinoma with PET.
Xu Q; Zhu C; Xu Y; Pan D; Liu P; Yang R; Wang L; Chen F; Sun X; Luo S; Yang M
J Drug Target; 2015; 23(9):813-20. PubMed ID: 25758750
[TBL] [Abstract][Full Text] [Related]
23. The Effects of an Albumin Binding Moiety on the Targeting and Pharmacokinetics of an Integrin α
Hausner SH; Bauer N; Davis RA; Ganguly T; Tang SYC; Sutcliffe JL
Mol Imaging Biol; 2020 Dec; 22(6):1543-1552. PubMed ID: 32383076
[TBL] [Abstract][Full Text] [Related]
24. In Vivo Evaluation and Dosimetry Estimate for a High Affinity Affibody PET Tracer Targeting PD-L1.
Rubins DJ; Meng X; McQuade P; Klimas M; Getty K; Lin SA; Connolly BM; O'Malley SS; Haley H; Purcell M; Gantert L; Holahan M; Lindgren J; Eklund P; Ekblad C; Frejd FY; Hostetler ED; González Trotter DE; Evelhoch JL
Mol Imaging Biol; 2021 Apr; 23(2):241-249. PubMed ID: 33098025
[TBL] [Abstract][Full Text] [Related]
25. Syntheses and preliminary evaluation of [(18) F]AlF-NOTA-G-TMTP1 for PET imaging of high aggressive hepatocellular carcinoma.
Li Y; Zhang D; Shi Y; Guo Z; Wu X; Ren JL; Zhang X; Wu H
Contrast Media Mol Imaging; 2016 Jul; 11(4):262-71. PubMed ID: 26931574
[TBL] [Abstract][Full Text] [Related]
26. Automated GMP compliant production of [
Tshibangu T; Cawthorne C; Serdons K; Pauwels E; Gsell W; Bormans G; Deroose CM; Cleeren F
EJNMMI Radiopharm Chem; 2020 Jan; 5(1):4. PubMed ID: 31997090
[TBL] [Abstract][Full Text] [Related]
27. In vitro and in vivo evaluation of the effects of aluminum [¹⁸F]fluoride radiolabeling on an integrin αvβ₆-specific peptide.
Hausner SH; Bauer N; Sutcliffe JL
Nucl Med Biol; 2014 Jan; 41(1):43-50. PubMed ID: 24267053
[TBL] [Abstract][Full Text] [Related]
28. One-step radiosynthesis of ¹⁸F-AlF-NOTA-RGD₂ for tumor angiogenesis PET imaging.
Liu S; Liu H; Jiang H; Xu Y; Zhang H; Cheng Z
Eur J Nucl Med Mol Imaging; 2011 Sep; 38(9):1732-41. PubMed ID: 21617974
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and Preclinical Evaluation of Folate-NOTA-Al(18)F for PET Imaging of Folate-Receptor-Positive Tumors.
Chen Q; Meng X; McQuade P; Rubins D; Lin SA; Zeng Z; Haley H; Miller P; González Trotter D; Low PS
Mol Pharm; 2016 May; 13(5):1520-7. PubMed ID: 27054811
[TBL] [Abstract][Full Text] [Related]
30. Preparation and Evaluation of [
Xiao D; Gan Q; Duan X; Wang Q; Jiang Y; Han P; Zhang J
Mol Pharm; 2023 Sep; 20(9):4528-4536. PubMed ID: 37661815
[TBL] [Abstract][Full Text] [Related]
31. Biological Evaluation of [
Lin L; Xiang X; Su S; Liu S; Xiong Y; Ma H; Yuan G; Nie D; Tang G
Front Chem; 2021; 9():630452. PubMed ID: 33937189
[No Abstract] [Full Text] [Related]
32.
Gao F; Zhang Y; Chen M; Song Z; Dong R; Qiu S; Shen C; Huang X; Geng H; Cheng W; Hu J
Eur J Pharm Sci; 2024 Feb; 193():106671. PubMed ID: 38104907
[TBL] [Abstract][Full Text] [Related]
33. MicroPET/CT imaging of patient-derived pancreatic cancer xenografts implanted subcutaneously or orthotopically in NOD-scid mice using (64)Cu-NOTA-panitumumab F(ab')2 fragments.
Boyle AJ; Cao PJ; Hedley DW; Sidhu SS; Winnik MA; Reilly RM
Nucl Med Biol; 2015 Feb; 42(2):71-7. PubMed ID: 25456837
[TBL] [Abstract][Full Text] [Related]
34. Comparison of Al
Gai Y; Yuan L; Sun L; Li H; Li M; Fang H; Altine B; Liu Q; Zhang Y; Zeng D; Lan X
J Biol Inorg Chem; 2020 Feb; 25(1):99-108. PubMed ID: 31745667
[TBL] [Abstract][Full Text] [Related]
35. A new (68)Ga-labeled BBN peptide with a hydrophilic linker for GRPR-targeted tumor imaging.
Pan D; Xu YP; Yang RH; Wang L; Chen F; Luo S; Yang M; Yan Y
Amino Acids; 2014 Jun; 46(6):1481-9. PubMed ID: 24633452
[TBL] [Abstract][Full Text] [Related]
36. Development of a Novel PET Tracer [18F]AlF-NOTA-C6 Targeting MMP2 for Tumor Imaging.
Liu Q; Pan D; Cheng C; Zhang D; Zhang A; Wang L; Jiang H; Wang T; Liu H; Xu Y; Yang R; Chen F; Yang M; Zuo C
PLoS One; 2015; 10(11):e0141668. PubMed ID: 26540114
[TBL] [Abstract][Full Text] [Related]
37. Pilot study of a novel (18)F-labeled FSHR probe for tumor imaging.
Xu Y; Pan D; Zhu C; Xu Q; Wang L; Chen F; Yang R; Luo S; Yang M; Yan Y
Mol Imaging Biol; 2014 Aug; 16(4):578-85. PubMed ID: 24389931
[TBL] [Abstract][Full Text] [Related]
38. Pre-clinical study of a TNFR1-targeted
Fu H; Wu H; Zhang X; Huang J; He X; Chen L; Guo W; Guo X; Hao B; Li Y
Amino Acids; 2018 Apr; 50(3-4):409-419. PubMed ID: 29243062
[TBL] [Abstract][Full Text] [Related]
39. The feasibility of 18F-AlF-NOTA-PRGD2 PET/CT for monitoring early response of Endostar antiangiogenic therapy in human nasopharyngeal carcinoma xenograft model compared with 18F-FDG.
Cui Y; Liu H; Liang S; Zhang C; Cheng W; Hai W; Yin B; Wang D
Oncotarget; 2016 May; 7(19):27243-54. PubMed ID: 27029065
[TBL] [Abstract][Full Text] [Related]
40. An Efficient Method for Labeling Single Domain Antibody Fragments with
Zhou Z; Devoogdt N; Zalutsky MR; Vaidyanathan G
Bioconjug Chem; 2018 Dec; 29(12):4090-4103. PubMed ID: 30384599
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
